Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain
Graphical abstract
Section snippets
Acknowledgments
The authors are grateful to Audrey Wang, Xing Cheng, Jing Zhong and Ivana Rajlic (for technical assistance) as well as Henry Verschoof (for helpful discussions during the preparation of this Letter).
References and notes (16)
- et al.
Lancet Neurol.
(2010)et al.Ann. Rept. Med. Chem.
(2008)et al.Pharmacol. Rev.
(2005)Expert Opin. Invest. Drugs
(2008)et al.Ann. Rev. Neurosci.
(2010) - et al.
Clin. Genet.
(2007)et al.Nature
(2006) - et al.
Tetrahedron
(2009) - et al.
J. Med. Genet.
(2004)et al.J. Neurosci.
(2004)et al.Neuron
(2006) - et al.
J. Med. Chem.
(1998) Curr. Bioact. Compd.
(2009)- et al.
Drug Metab. Dispos.
(2005)Drug Metab. Rev.
(2006)
There are more references available in the full text version of this article.
Cited by (128)
Base controlled rongalite-mediated reductive aldol/cyclization and dimerization of isatylidene malononitriles/cyanoacetates
2024, Organic and Biomolecular ChemistryMaleimide-Controlled Formation of Indanonylpyrrolinediones and Spiroindanonylpyrrolinediones via Rh(III)-Catalyzed C−H Activation of Sulfoxonium Ylides
2023, Advanced Synthesis and CatalysisSuperacid-Promoted synthesis of spirooxindoles
2023, Tetrahedron LettersZingiber zerumbet: A green and ecofriendly natural surfactant for the synthesis of Bis(indolyl)methane, tris-indoline and spirooxindole derivatives
2023, Sustainable Chemistry and PharmacyAdvances in Catalytic Asymmetric Construction of Quaternary Stereogenic Centers by Conjugate Addition to β,β-Disubstituted Nitroalkenes
2023, Advanced Synthesis and Catalysis
Copyright © 2011 Elsevier Ltd. All rights reserved.